BRTX BioRestorative: Accounting Value per Share

Graphic logo of biorestorative.com (BRTX)

A high dependence on external logistics and medical contractors is accelerating the development of the BRTX-100 drug for BioRestorative Therapies (BRTX), confirming the absolute level of the stock's book value, which currently stands at 2.40. The strategy is completed by a bet on personalized medicine and the therapy of metabolic disorders, creating a solid foundation for the long-term growth of the company's capitalization.

biorestorative.com - BRTX Net Assets per Share (period 07/04/2022 - 10/28/2026)

BioRestorative Therapies Inc - analytical breakdowns and key metrics (BRTX)

- price and consensus price forecast:
Stock Quotes BioRestorative|BRTX - Analyst Forecast Prices
- market capitalization data:
Market Valuation BioRestorative Therapies, Inc.|BRTX - Business Value
- book capitalization data:
Net Assets per Single Share BioRestorative Therapies|BRTX - Book Valuation of Business|Market Cap to Net Assets Ratio biorestorative.com|BRTX - Aggregate Business Assets
- debt and liquidity data:
Total Debt to Capital BioRestorative Therapies|BRTX - Long-Term Liabilities to Capital|Short-Term Debt to Equity BioRestorative|BRTX - Company Total Debt|Debts to Book Capitalization BioRestorative Therapies, Inc.
Analysis of all company metrics:biorestorative.com - BRTX
Finished products of BioRestorative

The visualization of the book value per share reflects the status of BioRestorative Therapies (BRTX) as a biotech startup heavily dependent on the success of the BRTX-100 drug. This indicator is calculated as the difference between all company assets and liabilities divided by the number of shares, allowing for an assessment of the real value of an investor's stake and capital stability while awaiting clinical trial results.

Competitors of BioRestorative Therapies (BRTX)

Accounting Value per Share Mesoblast Corp MESO|Lineage Corp (LCTX) - Book Price of a Share|Accounting Value per Share Surrozen, Inc.|CCEL (Cryo-Cell International, Inc.) - Equity per Share|FBLG: Net Assets per Single Share|Net Assets per Share Longeveron Inc (LGVN)|Accounting Value per Share Creative Medical Technology